# Cancer Therapy-related Cardiac Dysfunction Occuring in Children Treated by Anticancer Drugs for Malignancies

> **NCT05602103** · — · UNKNOWN · sponsor: **University Hospital, Caen** · enrollment: 10000 (estimated)

## Conditions studied

- Malignancies
- Cardiovascular Diseases
- Children, Only

## Interventions

- **DRUG:** use of anticancer drugs in monotherapy or in combination therapy

## Key facts

- **NCT ID:** NCT05602103
- **Lead sponsor:** University Hospital, Caen
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-11-05
- **Primary completion:** 2025-01-01
- **Final completion:** 2025-01-06
- **Target enrollment:** 10000 (ESTIMATED)
- **Last updated:** 2024-05-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05602103

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05602103, "Cancer Therapy-related Cardiac Dysfunction Occuring in Children Treated by Anticancer Drugs for Malignancies". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05602103. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*